Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. Cemiplimab

   Regeneron UK Limited

   Colo-rectal Cancer

   phase 2 · small molecule · active

   1 trial →

2. Cemiplimab

   Regeneron UK Limited

   Colorectal Cancer

   phase 2 · small molecule · active

   1 trial →

3. Cemiplimab

   Regeneron UK Limited

   Lung Cancer (NSCLC)

   phase 2 · small molecule · active

   1 trial →

4. Cemiplimab

   Regeneron UK Limited

   Hodgkin Lymphoma

   phase 2 · small molecule · terminated

   1 trial →

5. Cemiplimab

   Regeneron UK Limited

   Head and Neck Squamous Cell Carcinoma

   phase 2 · small molecule · active

   1 trial →

6. Cemiplimab

   Regeneron UK Limited

   Colon Cancer

   phase 2 · small molecule · active

   1 trial →

7. Cemiplimab

   Regeneron UK Limited

   Locally Recurrent Oral Cavity Squamous Cell Carcinoma

   phase 2 · small molecule · active

   1 trial →

8. Cemiplimab

   Regeneron UK Limited

   Colon and Rectal Cancer

   phase 2 · small molecule · active

   1 trial →

9. Cemiplimab

   Regeneron UK Limited

   Metastatic Solid Tumor

   phase 2 · small molecule · active

   1 trial →

10. Cemiplimab

    Regeneron UK Limited

    Carcinoma, Non-Small-Cell Lung

    phase 2 · small molecule · active

    1 trial →

11. Cemiplimab

    Regeneron UK Limited

    Basal Cell Carcinoma (BCC)

    phase 2 · small molecule · active

    1 trial →

12. Cemiplimab

    Regeneron UK Limited

    Locally Advanced Basal Cell Carcinoma

    phase 2 · mab · active

    1 trial →

13. Cemiplimab

    Regeneron UK Limited

    Bladder Urothelial Carcinoma

    phase 2 · small molecule · active

    1 trial →

14. Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)]

    Regeneron UK Limited

    Colon Cancer

    phase 2 · small molecule · active

    1 trial →

15. Cemiplimab 350 MG Intravenous Solution

    Regeneron UK Limited

    Clear Cell Renal Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

16. Cemiplimab 350 mg i.v. on day 1 of every 21 days cycle for 2 cycles

    Regeneron UK Limited

    Merkel Cell Carcinoma, Stage I

    phase 2 · small molecule · active

    1 trial →

17. Cemiplimab Plus Gemcitabine

    Regeneron UK Limited

    Pancreatic Ductal Adenocarcinoma (mPDAC)

    phase 2 · small molecule · active

    1 trial →

18. Cemiplimab-Rwlc

    Regeneron UK Limited

    Cutaneous Squamous Cell Carcinoma

    phase 2 · small molecule · terminated

    2 trials →

19. Cemiplimab-Rwlc

    Regeneron UK Limited

    Non-small Cell Lung Cancer Stage III

    phase 2 · small molecule · active

    1 trial →

20. Cemiplimab-Rwlc

    Regeneron UK Limited

    Head and Neck Squamous Cell Carcinoma

    phase 2 · small molecule · terminated

    1 trial →

21. Ceralasertib

    United Therapeutics Europe Ltd

    Gynaecological Cancers

    phase 2 · small molecule · active

    1 trial →

22. Ceritinib (LDK378)

    Novartis Pharmaceuticals

    Tumors With Aberrations in ALK

    phase 2 · small molecule · terminated

    1 trial →

23. Cetrelimab

    Janssen Cilag International NV

    Carcinoma, Non-Small-Cell Lung

    phase 2 · small molecule · active

    1 trial →

24. Cetuximab

    Hoffmann-La Roche

    Colorectal Cancer

    phase 2 · small molecule · completed

    1 trial →

25. Cetuximab

    Solid Biosciences

    Head and Neck Neoplasm

    phase 2 · small molecule · completed

    1 trial →

26. Cetuximab

    Merck KGaA, Darmstadt, Germany

    Metastatic Colorectal Cancer

    phase 2 · small molecule · completed

    1 trial →

27. Cetuximab β；Fruquintinib；

    Zhejiang University

    Colorectal Neoplasms

    phase 2 · small molecule · active

    1 trial →

28. ChAdOx1-MVA 5T4 vaccine

    Barinthus Biotherapeutics plc.

    Intermediate Risk Prostate Cancer

    phase 2 · mab · terminated

    1 trial →

29. ChAdOx1-PCAQ

    Barinthus Biotherapeutics plc.

    Prostate Cancer

    phase 2 · mab · terminated

    1 trial →

30. Chemotherapy + immunotherapy

    Hunan Province Tumor Hospital

    Non Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

31. Chemotherapy plus apatinib

    Lei Li

    Recurrent Cervical Carcinoma

    phase 2 · small molecule · completed

    1 trial →

32. Chemotherapy+PD-1 inhibitor+8Gy x 3f

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HR+HER2- Breast Cancer

    phase 2 · small molecule · active

    1 trial →

33. Chidamide

    Biotech Pharmaceutical Co.,

    Hepatocellular Carcinoma (HCC)

    phase 2 · small molecule · terminated

    1 trial →

34. Chidamide

    Sun Yat-sen University

    Peripheral T-cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

35. Chidamide

    Biotech Pharmaceutical Co.,

    Relapsed or Refractory Peripheral T-cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

36. Chidamide

    The First People's Hospital of Lianyungang

    Neuroendocrine Tumors

    phase 2 · small molecule · active

    2 trials →

37. Chidamide + Tislelizumab + chemotherapy (CapeOX )

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colon Adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

38. Chidamide combined with Duvillisib

    The First People's Hospital of Lianyungang

    Peripheral T Cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

39. Chinese Medicine Oral Rinse Formula-I (CMORF-I)

    Chinese University of Hong Kong

    Head and Neck Neoplasms

    phase 2 · small molecule · active

    1 trial →

40. Chlorambucil

    Teva Pharma GmbH

    Chronic Lymphocytic Leukemia

    phase 2 · small molecule · terminated

    1 trial →

41. Cholecalciferol

    Hospital Authority, Hong Kong

    Hematologic Neoplasms

    phase 2 · small molecule · active

    1 trial →

42. Cisplatin

    Ultragenyx UK Limited

    Squamous Cell Carcinoma of the Anus

    phase 2 · small molecule · active

    1 trial →

43. Cisplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cervical Cancer

    phase 2 · small molecule · active

    1 trial →

44. Cisplatin Accord Healthcare /ml concentraat v... for Vulvar cancer

    Disc Medicine

    Vulvar cancer

    phase 2 · small molecule · active

    1 trial →

45. Cisplatin and Doxorubicin

    Chinese University of Hong Kong

    Gastric Cancer Peritoneal Metastases

    phase 2 · small molecule · active

    1 trial →

46. Cisplatin+Capecitabine+Sintilimab

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

47. Clifutinib Besylate

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acute Myeloid Leukemia, Adult

    phase 2 · small molecule · active

    1 trial →

48. Clobetasol Propionate

    United Therapeutics Europe Ltd

    Colon Adenocarcinoma

    phase 2 · small molecule · completed

    1 trial →

Frequently asked questions